Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Alerts clinicians to emerging neurologic pathogens in travelers and immunocompromised patients; leaves open updated diagnostic and surveillance protocols.
The list of emerging and reemerging pathogens that cause neurologic disease is expanding. Various factors, including population growth and a rise in international travel, have contributed to the spread of pathogens to previously nonendemic regions. Recent advances in diagnostic methods have led to the identification of novel pathogens responsible for infections of the central nervous system. Furthermore, new issues have arisen surrounding established infections, particularly in an increasingly immunocompromised population due to advances in the treatment of rheumatologic disease and in transplant medicine.
No takes yet. Share an insight, caveat, or question.
Chow et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: